Hemi-chorea Due to Celiac Disease
Objective: To present a case of hemi-body chorea suspected to be secondary to Celiac disease Background: A wide range of neurologic symptoms have been seen…The Impact of DBS on Chorea- Acanthoctosis: Case Report
Objective: Chorea-acanthocytosis (ChAc) is the most common subtype of neuroacanthocytosis syndrome, characterized by the presence of misshaped spiky red blood cells (acanthocytes) and associated neurological…Post-infectious Anti-GFAP-associated meningoencephalitis: A case report
Objective: To report a clinical manifestation of severe choreoballistic movement in a patient with anti-glial fibrillary acidic protein (GFAP) antibody positive autoimmune encephalitis Background: GFAP…Normal chorein protein signal on Western blot despite VPS13A mutations in VPS13A disease
Objective: Follow up on patients with strong clinical evidence on VPS13A disease, despite normal chorein band expression in Western blot. Background: VPS13A disease is a…Medically refractory Graves’ disease presenting as chorea and carbohydrate hyperphagia in a Kenyan adolescent
Objective: To report a unique case of adolescent-onset autoimmune hyperthyroidism presenting with chorea and carbohydrate hyperphagia (CH). Background: Autoimmune hyperthyroidism [Graves’ disease (GD)] can cause…Hemichorea as an initial symptom of antibodies against contactin- associated protein-like 2 (CASPR2) encephalitis
Objective: Describe a case of hemichorea as the initial symptom of CASPR2 encephalitis. Background: The clinical spectrum of syndromes associated with CASPR2 is extensive and…Case of Chorea Hyperglycemia Basal Ganglia syndrome with normal glucose
Objective: To report a case of chorea hyperglycemia basal ganglia syndrome (CHBG) with normal glucose. Background: Elderly persons with CHBG usually have high glucose (average…Pilot study to evaluate pimavanserin for the treatment of motor and behavioral symptoms of Tourette syndrome.
Objective: To determine whether pimavanserin has an effect on motor and behavioral aspects of Tourette syndrome (TS). Background: Pimavanserin is a serotonin 2A receptor inverse…Absence of neutralizing antibody formation during incobotulinumtoxinA treatment of spasticity in botulinum toxin-naïve children with cerebral palsy: pooled analysis of Phase 3 studies
Objective: To investigate neutralizing antibody (NAb) formation in three large Phase 3 studies with incobotulinumtoxinA, a botulinum neurotoxin type A (BoNT-A) with no complexing proteins,…Predictors of Persistence to Deutetrabenazine Among Patients With Tardive Dyskinesia (TD) and Huntington’s Disease (HD)
Objective: To identify real-world predictors of persistence to deutetrabenazine in patients with TD or HD. Background: Deutetrabenazine is FDA-approved to treat TD in adults and…
- « Previous Page
- 1
- …
- 702
- 703
- 704
- 705
- 706
- …
- 1734
- Next Page »